Company news
Skylight Health Group Inc. (OTC:SLHGF) news
Skylight Health Group Inc. news releases on 6ix. Latest, Jul 8, 2020: CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020
Press releases — page 3
CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020
July 8, 2020
CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020
June 29, 2020
CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%
June 17, 2020
CB2 Insights Announces Amendments to Promissory Note held by Merida Capital Partners
June 18, 2020
CB2 Insights Announces Delay in Filing Annual Financial Statements
June 15, 2020
CB2 Insights Announces Delay in Filing Financials and Year End 2019 Financial Results Conference Call
June 10, 2020
CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan
May 7, 2020
CB2 Insights Introduces Insurable Medical Services to Patients in the United States with Launch of Skylight Health Group
April 29, 2020
CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates
April 20, 2020
CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief under COVID-19 Duress
April 15, 2020
CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders
March 30, 2020
CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors
January 29, 2020
CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine
January 27, 2020
CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial
January 14, 2020
CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar
January 8, 2020
CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly Freedom Leaf Inc.)
December 16, 2019
CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems
December 12, 2019
CB2 Insights Launches Warrant Incentive Program
December 11, 2019
CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia
December 3, 2019
CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference
November 14, 2019
CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%
November 8, 2019
CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call
November 1, 2019
VIVO and CB2 Insights Enter Technology and Research Partnership
October 29, 2019
CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK
September 19, 2019
CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus
September 3, 2019
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
August 28, 2019
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
August 20, 2019
CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive
August 1, 2019
CB2 Insights Adds Former Johnson & Johnson Executive as Director
July 31, 2019
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
July 18, 2019
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
July 9, 2019
CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics
June 25, 2019
CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update
June 24, 2019
CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019
May 30, 2019
CB2 Insights to Present at the 9th Annual LD Micro Invitational in Bel-Air
May 28, 2019
CB2 Insights to Host Q12019 Earnings Call on May 31, 2019
May 27, 2019
CB2 Insights Announces Ticker Symbol Change on OTCQB
May 17, 2019
CB2 Insights Expands Board with Teladoc Executive Marc Adelson, Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw
May 2, 2019
CB2 Insights Announces FY2018 Financial Results After Transformative Year
April 30, 2019
OTC Markets Group Welcomes New OTCQB Companies – April 29
April 29, 2019